Understanding the U.S. Biosimilar Pathway in 2012 An In-Depth Look at the Debate and Its Implications

FDAnews has called on two experts in regulatory law, Covington & Burling’s Erika Lietzen and Laura Sim, to explain what the FDA is trying to do, how the public comments might change the landscape and what you need to know NOW in order to stay out in front.


Audio CD/Transcript - June 28, 2012 The Audio CD/Transcript will be shipped the week of July 23, 2012.